Department of Internal Medicine 5, Hematology/Oncology, Friedrich Alexander University Erlangen-Nuremberg, Erlangen, Germany.
Experimental and Clinical Research Center, Berlin, Germany.
J Clin Invest. 2019 Jun 17;129(7):2952-2963. doi: 10.1172/JCI123105.
Recent studies have demonstrated that CD4+ T cells can efficiently reject MHC-II-negative tumors. This requires indirect presentation of tumor-associated antigens on surrounding antigen-presenting cells. We hypothesized that intercellular transfer of proteins is not the sole consequence of cell death-mediated protein release, but depends on heat-shock cognate protein 70 (HSC70) and its KFERQ-like binding motif on substrate proteins. Using human Y chromosome antigen DBY, we showed that mutation of one of its 2 putative binding motifs markedly diminished T cell activation after indirect presentation and reduced protein-protein interaction with HSC70. Intercellular antigen transfer was shown to be independent of cell-cell contact, but relied on engulfment within secreted microvesicles. In vivo, alterations of the homologous KFERQ-like motif in murine DBY hampered tumor rejection, T cell activation, and migration into the tumor and substantially impaired survival. Collectively, we show that intercellular antigen transfer of DBY is tightly regulated via binding to HSC70 and that this mechanism influences recognition and rejection of MHC-II-negative tumors in vivo.
最近的研究表明,CD4+ T 细胞可以有效地排斥 MHC-II 阴性肿瘤。这需要在周围的抗原呈递细胞上间接呈现肿瘤相关抗原。我们假设细胞死亡介导的蛋白质释放并非是细胞间蛋白质转移的唯一后果,而是取决于热休克同源蛋白 70(HSC70)及其在底物蛋白上的 KFERQ 样结合基序。使用人类 Y 染色体抗原 DBY,我们表明,其 2 个假定结合基序之一的突变会显著降低间接呈递后 T 细胞的激活,并减少与 HSC70 的蛋白质-蛋白质相互作用。细胞间抗原转移不依赖于细胞-细胞接触,而是依赖于在分泌的微泡内的吞噬作用。在体内,对鼠源 DBY 中同源 KFERQ 样基序的改变会阻碍肿瘤排斥、T 细胞激活和向肿瘤迁移,并严重影响生存。总的来说,我们表明,DBY 的细胞间抗原转移通过与 HSC70 结合而受到严格调控,并且这种机制会影响 MHC-II 阴性肿瘤在体内的识别和排斥。